 |
Articles: Drug/Product Alerts |
Prior Articles
FDA Approves Boston Scientific's Next-Generation TAXUS Liberte Atom Stent System
Boston Scientific, 05/28/09
Free full text
Angiotech pharmaceuticals announces fda approval of nextgeneration taxus liberte atom stent
Angiotech Pharmaceuticals, 05/28/09
Free full text
Allos Therapeutics Announces FDA Accepts Pralatrexate NDA for Filing and Grants the Application Priority Review Status
Allos Therapeutics, 05/27/09
Free full text
FDA Grants Full Approval for SPRYCEL (dasatinib) for the Treatment of Adults with Chronic Myeloid Leukemia Who Are Resistant or Intolerant to Prior Therapies Including Gleevec
Bristol Myers-Squibb Company, 05/27/09
Free full text
FDA Approves Samsca to Treat Hyponatremia
FDA Press Releases, 05/26/09
Free full text
U.S. Department of Agriculture grants approval for Bayer CropScience's GlyTol cotton technology
BayNews International, 05/26/09
Free full text
European approvals for Levocetirizine
Synthon, 05/26/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/22/09
Free full text
Medtronic Announces FDA Approval of Two Deep Brain Stimulation Devices That Offer Programming Advances and New Tools for Patients with Movement Disorders
Medtronic, 05/22/09
Free full text
Taro Receives FDA Approval for Sulfacetamide Sodium Topical Suspension ANDA
Taro Pharmaceuticals USA, 05/22/09
Free full text
Avigen Granted AV411 Patent for Neuropathic Pain
Avigen, 05/21/09
Free full text
Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
BayNews International, 05/21/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/21/09
Free full text
Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
Onyx Pharmaceuticals, 05/21/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/20/09
Free full text
Genentech and Biogen Idec Submit Applications to the FDA for Rituxan for Most Common Type of Adult Leukemia
Genentech, 05/20/09
Free full text
Endeavor Drug-Eluting Stent Is First to Receive CE Mark for Treating Acute Coronary Syndrome
Medtronic, 05/20/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/19/09
Free full text
DA Grants Approval for Use of RISPERDAL CONSTA as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
Janssen, 05/19/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/18/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
143 Available Pages
|
|
